Mary E. Sayler
- Pharmacology top 2%
- Psychiatry and Mental health top 5%
- Experimental and Cognitive Psychology top 5%
- Clinical Psychology top 10%
- Cellular and Molecular Neuroscience
- Co-authors
- Charles M. BeasleyJanet H. PotvinGary D. TollefsonJ C BosomworthDaniel N. MasicaAlvin H. RampeyBruce E. DornseifDenis Murphy
- Topics
- Treatment of Major Depression (19 papers)Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers)Attention Deficit Hyperactivity Disorder (8 papers)
- Partner nations
- United States
In The Last Decade
Mary E. Sayler
25 papers receiving 763 citations
Peers
Comparison fields: 5 of 61
- Pharmacology 561
- Psychiatry and Mental health 385
- Experimental and Cognitive Psychology 300
- Clinical Psychology 239
- Cellular and Molecular Neuroscience 96
Countries citing papers authored by Mary E. Sayler
This map shows the geographic impact of Mary E. Sayler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Sayler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Sayler more than expected).
Fields of papers citing papers by Mary E. Sayler
This network shows the impact of papers produced by Mary E. Sayler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Sayler. The network helps show where Mary E. Sayler may publish in the future.
Co-authorship network of co-authors of Mary E. Sayler
This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Sayler. A scholar is included among the top collaborators of Mary E. Sayler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Sayler. Mary E. Sayler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 26 | |
| 5 | 1 | |
| 6 | Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior. | 15 |
| 7 | 2 | |
| 8 | 44 | |
| 9 | 5 | |
| 10 | Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. | 113 |
| 11 | 43 | |
| 12 | 27 | |
| 13 | 40 | |
| 14 | 37 | |
| 15 | 56 | |
| 16 | 4 | |
| 17 | 9 | |
| 18 | 45 | |
| 19 | 40 | |
| 20 | 35 |
About Mary E. Sayler
Mary E. Sayler is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Psychiatry and Mental health, having authored 26 papers that have together received 834 indexed citations. Recurring topics across this work include Treatment of Major Depression (19 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (12 papers) and Attention Deficit Hyperactivity Disorder (8 papers). The work is most often cited by research in Pharmacology (561 citations), Psychiatry and Mental health (385 citations) and Biological Psychiatry (59 citations). Mary E. Sayler has collaborated with scholars based in United States. Frequent co-authors include Charles M. Beasley, Janet H. Potvin, Gary D. Tollefson, J C Bosomworth, Daniel N. Masica, Alvin H. Rampey, Bruce E. Dornseif, Denis Murphy, Anupam Pande and Arindam Pande. Their work appears in journals such as Biological Psychiatry, Journal of Affective Disorders and Schizophrenia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.